Bicocca Open Archive

Logo unimib boa
CRISTOFERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.839
AS - Asia 4.402
EU - Europa 3.974
SA - Sud America 705
Continente sconosciuto - Info sul continente non disponibili 364
AF - Africa 119
OC - Oceania 4
Totale 16.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.499
SG - Singapore 1.475
IT - Italia 1.391
CN - Cina 787
VN - Vietnam 763
HK - Hong Kong 611
RU - Federazione Russa 554
BR - Brasile 518
DE - Germania 480
SE - Svezia 454
IE - Irlanda 266
CA - Canada 243
GB - Regno Unito 226
IN - India 158
FR - Francia 154
BD - Bangladesh 101
KR - Corea 89
AR - Argentina 75
ID - Indonesia 64
FI - Finlandia 63
NL - Olanda 61
ES - Italia 51
TR - Turchia 50
CH - Svizzera 48
IQ - Iraq 46
AT - Austria 40
UA - Ucraina 39
ZA - Sudafrica 38
MX - Messico 37
PK - Pakistan 34
MY - Malesia 33
PL - Polonia 29
EC - Ecuador 28
JP - Giappone 28
PH - Filippine 26
SA - Arabia Saudita 24
CO - Colombia 23
DK - Danimarca 23
VE - Venezuela 22
UZ - Uzbekistan 19
BE - Belgio 17
JM - Giamaica 16
IL - Israele 14
LT - Lituania 14
CL - Cile 13
MA - Marocco 13
PY - Paraguay 13
KE - Kenya 12
EG - Egitto 11
ET - Etiopia 10
JO - Giordania 10
PT - Portogallo 9
TN - Tunisia 9
TW - Taiwan 9
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
CR - Costa Rica 7
GR - Grecia 7
RS - Serbia 7
CZ - Repubblica Ceca 6
HN - Honduras 6
NO - Norvegia 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
DZ - Algeria 5
PA - Panama 5
BA - Bosnia-Erzegovina 4
KZ - Kazakistan 4
MM - Myanmar 4
PE - Perù 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
GD - Grenada 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MU - Mauritius 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
CG - Congo 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
IR - Iran 2
KH - Cambogia 2
MO - Macao, regione amministrativa speciale della Cina 2
SV - El Salvador 2
TJ - Tagikistan 2
Totale 16.015
Salva come PNG Salva come JPEG
Città #
Singapore 909
Ann Arbor 862
Ashburn 590
Hong Kong 590
San Jose 581
Milan 440
Frankfurt am Main 369
Dublin 253
Chicago 234
Fairfield 231
New York 226
Chandler 221
Ho Chi Minh City 212
Los Angeles 194
Toronto 186
Hanoi 183
Wilmington 182
Hefei 153
Council Bluffs 150
Santa Clara 138
Beijing 133
Dallas 121
Rome 118
The Dalles 108
Seattle 105
Woodbridge 105
Houston 100
London 100
Boardman 98
Seoul 84
Cambridge 81
Princeton 73
Lauterbourg 71
Buffalo 68
Shanghai 68
Columbus 60
São Paulo 58
Dearborn 44
Moscow 44
Jakarta 43
Zurich 43
Helsinki 42
Denver 39
Florence 36
Lawrence 35
Orem 35
Munich 32
Monza 31
Altamura 28
Turin 27
Haiphong 26
Phoenix 26
Tokyo 25
Warsaw 25
Da Nang 24
Montreal 23
Brooklyn 22
San Diego 22
Johannesburg 21
Naples 21
Chennai 20
Pune 20
Rio de Janeiro 19
Atlanta 18
Bologna 18
Manchester 18
Ninh Bình 18
Nuremberg 18
Biên Hòa 17
Can Tho 17
Mumbai 17
Tashkent 17
Brentwood 16
Brussels 16
Nanjing 16
Paris 16
Penang 16
Poplar 16
Vienna 16
Jacksonville 15
New Delhi 15
Salt Lake City 15
Baghdad 14
Modena 14
Elk Grove Village 13
San Francisco 13
Stockholm 13
Washington 13
Amsterdam 12
Andover 12
Bari 12
Genoa 12
Hải Dương 12
Istanbul 12
Mexico City 12
Baltimore 11
Boston 11
Campinas 11
Guarulhos 11
Ha Long 11
Totale 9.762
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 616
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 425
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 400
Endocrinology and Metabolic Diseases (Including Diabetes) 365
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 361
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 353
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 351
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 343
Risk stratification in primary sclerosing cholangitis 343
Precision medicine in primary biliary cholangitis 339
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 331
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 328
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 326
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 313
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 303
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 300
New Therapeutic Targets in Autoimmune Cholangiopathies 297
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 296
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 294
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 284
An update on novel pharmacological agents for primary sclerosing cholangitis 267
Artificial intelligence for precision medicine in autoimmune liver disease 264
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 263
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 261
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 260
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 258
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 258
Prognostic models in primary biliary cholangitis 256
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 247
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 245
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 244
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 240
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 238
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 234
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 232
Non-invasive imaging biomarkers in chronic liver disease 231
Fibrocystic liver disease 228
X marks the spot in autoimmunity 226
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 221
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 215
The immunobiology of female predominance in primary biliary cholangitis 214
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 202
The Role of Epigenetics in Primary Biliary Cholangitis 199
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 195
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 191
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 190
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 190
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 186
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 185
A Smooth Esophageal Stricture Causing Dysphagia 174
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 173
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 172
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 166
Individualizing Care: Management Beyond Medical Therapy 164
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 160
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 159
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 156
Antioxidant treatment for acute pancreatitis 149
Systematic review-Pancreatic involvement in inflammatory bowel disease 146
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 145
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 143
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 127
Primary Sclerosing Cholangitis 123
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 121
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 117
Elastography in Autoimmune Liver Diseases 113
Individualizing Care: Management Beyond Medical Therapy 110
Transient elastography in chronic liver disease: beware to the cut-offs! 107
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 74
Totale 16.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022574 0 0 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20252.845 195 303 153 143 233 130 191 111 302 421 260 403
2025/20267.138 934 531 494 770 683 346 1.046 309 519 597 411 498
2026/2027962 287 369 306 0 0 0 0 0 0 0 0 0
Totale 16.407